| 239.13 1.83 (0.77%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 282.11 | 1-year : | 288.2 |
| Resists | First : | 241.53 | Second : | 246.75 |
| Pivot price | 239.4  |
|||
| Supports | First : | 233.09 | Second : | 193.93 |
| MAs | MA(5) : | 237.5 |
MA(20) : | 240.3 |
| MA(100) : | 224.71 |
MA(250) : | 199.79 |
|
| MACD | MACD : | -0.2 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 38.4 |
D(3) : | 34.5 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 246.75 | Low : | 163.36 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COR ] has closed above bottom band by 48.0%. Bollinger Bands are 3.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 240.13 - 241.08 | 241.08 - 241.91 |
| Low: | 234.32 - 235.51 | 235.51 - 236.53 |
| Close: | 237.09 - 239.02 | 239.02 - 240.68 |
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Fri, 19 Apr 2024
Insider Selling: Cencora, Inc. (NYSE:COR) COO Sells 57564 Shares of Stock - Defense World
Fri, 19 Apr 2024
Insider Selling: Cencora, Inc. (NYSE:COR) CEO Sells 10754 Shares of Stock - Defense World
Thu, 18 Apr 2024
At Cencora, Steven H Collis Chooses To Exercise Options, Resulting In $1.60M - Cencora (NYSE:COR) - Benzinga
Thu, 18 Apr 2024
Executive Vice President & COO Robert Mauch Sells 57564 Shares of Cencora Inc (COR) - Yahoo Finance UK
Thu, 18 Apr 2024
Insider Sell: Cencora Inc (COR) Chairman, President & CEO Steven - GuruFocus.com
Wed, 17 Apr 2024
Insider Selling: Cencora, Inc. (NYSE:COR) CEO Sells 10,754 Shares of Stock - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 199 (M) |
| Shares Float | 172 (M) |
| Held by Insiders | 13.5 (%) |
| Held by Institutions | 87.4 (%) |
| Shares Short | 8,110 (K) |
| Shares Short P.Month | 8,390 (K) |
| EPS | 9.17 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.57 |
| Profit Margin | 0.6 % |
| Operating Margin | 1 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 327.7 % |
| Qtrly Rev. Growth | 15 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1362.87 |
| EBITDA (p.s.) | 18.76 |
| Qtrly Earnings Growth | 27.8 % |
| Operating Cash Flow | 4,090 (M) |
| Levered Free Cash Flow | 5,720 (M) |
| PE Ratio | 26.07 |
| PEG Ratio | 1.7 |
| Price to Book value | 52.32 |
| Price to Sales | 0.17 |
| Price to Cash Flow | 11.65 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|